Category Archive: Uncategorized


In an interview with Marce Redondo, José Luis Berenguer, chairman of Farmalíder explains how the company has achieved growth by associating with foreign companies and investing in R&D.

José Luis Berenguer, who studied Economics in Madrid and has led Farmalíder since it was founded 25 years ago, emphasises the importance in business today of having a global perspective and creating synergies with other partners. The company’s most recent project, Eurogel, is a joint venture with India’s Geltec – which makes soft gel capsules – in which each have a 50% stake, and which involves an investment of about €4 mill. over three years. This is one of a number of projects involving emerging markets, where Farmalíder is focusing because this is where more innovation is taking place. The products will go on sale all over Europe.

Berenguer very much regrets the decline in innovation caused by the recent closure of Spanish research centres and the resulting job losses for highly specialized people who had opted to stay in research in Spain rather than accepting lucrative posts abroad. Farmalíder, on the other hand, has not only been able to maintain its jobs but has more than doubled its workforce, which reached 105 in 2013. It is one of the few Spanish companies that has managed to grow in the current climate, despite being limited by the crisis.

For 2013, Berenguer forecasts growth of 15% – a remarkable figure when the sector is in decline. The aim is to consolidate the domestic market, develop the global market – particularly in emerging countries – extend its portfolio of 42 products and invest €8 mill. on the launch of seven products this year, for which it is seeking global investors. Farmalíder is concentrating on areas where competition is less fierce, such as ophthalmology, dermatology, central nervous system and women’s health. It will also be making its stock market debut and looking for partners for 20% of its treasury stock. It will continue to focus on R&D, for which it earmarks between 10 and 15% of its earnings.





Entrevista con el presidente de Farmalider José Luis Berenguer – Click here



FARMALIDER, Laboratorio de innovación e ideas

Mercado De Dinero – Febrero 2013

La farmacéutica aparta valor añadido a medicamentos genéricos, desarrolla productos propios y está presente en varios países.

Puedes ampliar la noticia, haciendo Click Aquí


Turning Ideas into Medicine

With just 42 employees, Farmalíder turned over €25 mill. in 2011 thanks to a formula based on team-based innovation and creativity.

Small Spanish pharmaceutical company Farmalíder is pulling through the crisis in its sector. It has offices in New Zealand, Turkey and Florida, and turnover is growing every year. The secret, according to Chairman José Luis Berenguer, is a working model called the “Ideas Factory” built on team-based innovation and creativity.

Founded in Madrid in 1986, Farmalíder specialises in R&D in generic drugs and identifies molecules with medical and pharmacological applications. It tailors its resources to the needs of pharmaceuticals giants and helps them get more from their patents. Berenguer is keen to stress the importance of generic drugs, which can take 10 years to develop and are part of the innovative process required to stay competitive. Farmalíder already has 30 products on the market and is working on 20 more – seven with guaranteed market entry. To achieve this, it is looking for financing of about €20 mill., and is contemplating stock market launch.

Farmalíder, which itself spends 30% of turnover on RD&I, is particularly concerned about government cutbacks in this area. Berenguer sees this as a mistake, causing the loss of research teams that have taken many years to form. Farmalíder is also committed to the welfare of its workers who enjoy flexible hours and a pleasant working environment. “An employee who is happy in their post works harder and better”, he adds.

Turning Ideas into Medicine